Interstitial pneumonia was the first manifestation to be recognized as caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2); however, in just a few weeks, it …

The prevailing coronavirus disease-19 (COVID-19) caused by a novel severe acute
respiratory syndrome coronavirus (SARS-CoV-2) has presented some neurological …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a newly emerged
coronavirus, has sparked a global pandemic with its airborne transmission and ability to …

SARS-CoV-2 infects cells through angiotensin-converting enzyme 2 (ACE2), a ubiquitous
receptor that interacts with the virus' surface S glycoprotein. Recent reports show that the …

Increasing evidence suggests that Severe Acute Respiratory Syndrome-coronavirus-2
(SARS-CoV-2) can also invade the central nervous system (CNS). However, findings …

Abstract Coronavirus (COVID-19) is a highly infectious respiratory infection discovered in
Wuhan, China, in December 2019. As a result of the pandemic, several individuals have …

Angiotensin‐converting enzyme 2 (ACE2), a key enzyme in the renin–angiotensin system
(RAS), is expressed in various tissues and organs, including the central nervous system …

Abstract Coronavirus disease 2019 (COVID-19), a disease caused by the novel
betacoronavirus (SARS-CoV-2), has become a global pandemic threat. The potential …

There is increasing evidence of neurological manifestations and complications in patients
with coronavirus disease 19 (COVID-19). More than one-quarter of patients with COVID-19 …

OBJECTIVE: The pandemic of Coronavirus Disease 2019 (COVID-19) caused by Severe
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues, and SARS-CoV-2 …